Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.11 | 0.15 | 0.04 |
Stocks | 97.96 | 97.96 | 0.00 |
Other | 1.93 | 2.08 | 0.15 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.36 | 19.79 |
Price to Book | 4.90 | 4.61 |
Price to Sales | 3.99 | 2.61 |
Price to Cash Flow | 14.69 | 17.79 |
Dividend Yield | 0.94 | 1.06 |
5 Years Earnings Growth | 17.65 | 14.76 |
Number of long holdings: 189
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 11.45 | 171.56 | -1.23% | |
Amgen | US0311621009 | 8.83 | 272.11 | +0.99% | |
Krystal Biotech | US5011471027 | 7.80 | 148.39 | +2.47% | |
Vertex | US92532F1003 | 4.66 | 422.00 | +1.21% | |
Alnylam | US02043Q1076 | 3.47 | 246.27 | -1.16% | |
Regeneron Pharma | US75886F1075 | 3.26 | 681.58 | -1.68% | |
Gilead | US3755581036 | 3.23 | 91.84 | +0.21% | |
argenx ADR | US04016X1019 | 2.23 | 640.52 | -2.92% | |
UCB | BE0003739530 | 2.20 | 182.50 | -4.60% | |
Arcellx Inc | - | 1.94 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 619.45B | 25.00 | 8.93 | 13.09 | ||
Fidelity Contrafund | 128.94B | 35.97 | 10.77 | 15.29 | ||
Fidelity Contrafund K | 128.94B | 36.05 | 10.85 | 15.38 | ||
Fidelity Total Market Index Instl b | 104.68B | 23.88 | 7.94 | 12.50 | ||
Fidelity Blue Chip Growth | 67.04B | 39.70 | 10.19 | 18.10 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review